In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route-Reference-Cited by-同舟云学术

In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route

Published:2024-05-06 Issue:5 Volume:25 Page:
ISSN:1530-9932
Container-title:AAPS PharmSciTech
language:en
Short-container-title:AAPS PharmSciTech

Author:

Ghosh Arya,Majie Ankit,Karmakar Varnita,Chatterjee Kaberi,Chakraborty Swarup,Pandey Manisha,Jain Neha,Roy Sarkar Suparna,Nair Anroop B.,Gorain Bapi^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1208/s12249-024-02810-0.pdf

Reference162 articles.

1. Homayun B, Lin X, Choi H-J. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 2019;11:129.

2. Dechant JE. (2021) Complications of parenteral administration of drugs. Complications in Equine Surgery. Wiley 10–5.

3. Keller L-A, Merkel O, Popp A. Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res. 2022;12:735–57.

4. Zheng S, Guo Y, Yan F, Yan F, Qi R, Shen J. Chances and challenges in intranasal administration delivery for brain disease treatment. Clin Trans Discov. 2023;3:e253.

5. Jeong S-H, Jang J-H, Lee Y-B. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J Pharm Investig. 2023;53:119–52.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLGA Nanoparticles Based Mucoadhesive Nasal In Situ Gel for Enhanced Brain Delivery of Topiramate;AAPS PharmSciTech;2024-09-05